Project description
Fighting against the antimicrobial resistance health threat
Antimicrobial resistance (AMR) is a serious global problem threatening the effective prevention and treatment of a range of infections. Tackling this, the EU-funded JPIAMR-ACTION project, an ERA-NET Cofund, will support research and innovation to develop strategies and methodologies that will decrease the transmission and spread of AMR within a full One Health spectrum. Key to achieving this is the JPIAMR-ACTION co-funded call that aims to bring to light the impact of interventions on the development and transmission of antibiotic resistance, among other goals. This call, along with other activities, will deliver new approaches, and enhance existing actions, aimed at interventions that will stop AMR in humans, animals and the environment in its tracks.
Objective
In the past 90 years since their discovery, antibiotics have saved millions of lives from bacterial diseases. However, emerging resistance to antimicrobials now threatens many advances achieved in modern medicine. AMR is a critical global health issue tightly linked with the One Health concept, which recognises that human and animal health are inextricably linked, and that diseases are transmitted from humans to animals and vice versa. One Health also encompasses the environment as another link between humans and animals and a potential source and reservoir of AMR. Antimicrobial resistance is a growing global health concern and threatens the future treatment and health of humans and animals. In addition, AMR limits our ability to achieve several of the UN Sustainable Development Goals (SDGs). The global challenge to address AMR goes beyond the production of new antibiotics and therapies. Reducing demand for new antibiotics through public awareness, infection prevention and control, prudent and rational use of antibiotics for humans and animals, as well as effective diagnosis and surveillance of antibiotic-resistant infections and monitoring antibiotic use, are crucial when dealing with this problem globally. The transmission and spread of AMR in and between One Health compartments is complex, which emphasises the need for comprehensive interventions to reverse the trend of increasing human and animal infections resistant to treatment. The ERA-NET Cofund JPIAMR-ACTION will tackle this central challenge by supporting research and innovation for the development and testing of strategies and methodologies to reduce the transmission and spread of AMR within a full One Health spectrum. The JPIAMR-ACTION co-funded call and other activities will be instrumental in producing new innovative approaches, and advancing existing actions towards the development of new and improved interventions to inhibit or limit the development of AMR in humans, animals and the environment.
Fields of science
Programme(s)
Funding Scheme
ERA-NET-Cofund - ERA-NET CofundCoordinator
101 38 Stockholm
Sweden
See on map
Participants (25)
75013 Paris
See on map
00531 Helsinki
See on map
28071 Madrid
See on map
9101002 Jerusalem
See on map
K1T 4H8 Ottawa Ontario
See on map
C1425FQB Buenos Aires
See on map
51147 Koln
See on map
1000 Bruxelles / Brussel
See on map
20124 Milano
See on map
D02 H638 Dublin
See on map
28029 Madrid
See on map
00144 Roma
See on map
SN2 1FL Swindon
See on map
1100 Kobenhavn K
See on map
30 312 Krakow
See on map
2004 CHISINAU
See on map
0283 Oslo
See on map
1050 Riga
See on map
2593 CE DEN HAAG
See on map
53175 Bonn
See on map
1000 Bruxelles / Brussel
See on map
LT-01103 Vilnius
See on map
1077 Budapest
See on map
51004 Tartu
See on map
NA Dublin 2
See on map